Pediatric Vaccines Market is expected to reach US$ 66.78 Bn. at a CAGR of 10.7% during the forecast period 2029. Pediatric Vaccine work as protecting shield administered to a child in its paediatric age that is from new born to 18 years of age. Vaccines are normally given in order to prevent children from diseases transmitted through infections, seasonal variations and even through unhygienic areas. The report study has analyzed revenue impact of covid-19 pandemic on the sales revenue of market leaders, market followers and disrupters in the report and same is reflected in our analysis.To know about the Research Methodology :- Request Free Sample Report The global pediatric vaccines market is expected to increase at a CAGR during the forecast period, owing to the growing engagement of various government healthcare as well as private organizations. Rising immunization alertness and destroying the pediatric infectious disease are also boosting the growth of the pediatric vaccines market. Rise in incidence of diseases like chicken pox, typhoid, cholera, measles, and hepatitis, in kids are propelling the growth of the market. However, low availability to remote areas, growing accessibility of biosimilars at low rates, and increasing cost of vaccines are hampering the growth of the market. Based on vaccine type, the monovalent vaccine segment is projected to increase maximum rate during the forecast period, owing to growing usage of monovalent vaccine in preventing pediatric infectious disease. The monovalent vaccine is stable, safe and has the ability to develop a rapid immune response, thus it is boosting the growth of the monovalent vaccine in the pediatric vaccines market during the forecast period. Conjugate vaccine holds major market share in the vaccine segment, owing to their high usefulness over specific types of infectious microorganism, thus providing a strong immune response to a specific disease condition. Inactivated vaccines are antigenic substances composed of inactivated material from a pathogen such as a virus and a bacterium. An inactivated vaccine consisting virus such as particles, bacteria, and other pathogens that have been grown in culture and then killed using a method like heat and formaldehyde.
Infectious disease segment is accounted for the major share in the pediatric vaccine application market, owing to the growing occurrence of pediatric infectious disease worldwide. Growing global awareness about immunization against a number of infectious diseases that cause mortality as well as morbidity is also propelling the growth of the infectious disease in the global pediatric vaccines market. The Asia Pacific is expected to showcase the highest growth rate in market during the forecast period, owing to an increasing larger population. The growing healthcare sector in leading regions such as China and India is boosting the growth of the Asia Pacific. European market is the rise, due to the superior government spending such as (NHS) nation healthcare service for the development of the pharmaceutical as well as medical industries. The Middle East & Africa region is expected to grow at a steady pace, owing to the rising research and development activities in the healthcare sector as well as extensive development of healthcare infrastructure. The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data and projections with a suitable set of assumptions and methodology. The report also helps in understanding global pediatric vaccines market dynamics, structure by identifying and analyzing the market segments and project the global market size. Further, report also focuses on competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence. The report also provides PEST analysis, PORTER’s analysis, SWOT analysis to address questions of shareholders to prioritizing the efforts and investment in near future to emerging segment in pediatric vaccines market.
Pediatric Vaccines Market Scope: Inquire before buying
Pediatric Vaccines Market Base Year 2022 Forecast Period 2023-2029 Historical Data CAGR Market Size in 2022 Market Size in 2029 2018 to 2022 10.7% US$ 32.78 Bn US$ 66.78 Bn Segments Covered by Vaccine Type Monovalent Multivalent by Technology Attenuated Live Viruses Inactivated Viruses Recombinant Subunits Toxoids Conjugates Polysaccharides by Application Infectious Disease Allergy Cancer Other by End-Use Hospitals Pediatric Clinics Others Regions Covered North America United States Canada Mexico Europe UK France Germany Italy Spain Sweden Austria Rest of Europe Asia Pacific China SKorea Japan India Australia Indonesia Malaysia Vietnam Taiwan Bangladesh Pakistan Rest of APAC Middle East and Africa South Africa GCC Egypt Nigeria Rest of ME&A South America Brazil Argentina Rest of South America Key Players
1. Merck Sharp & Dohme Corp 2. SANOFI 3. Indian Immunologicals Limited 4. Mitsubishi Tanabe Pharma Corporation 5. Sinovac Biotech Ltd. 6. GlaxoSmithKline plc. 7. Serum Institute of India Pvt. Ltd. 8. Eli Lilly Company 9. Pfizer, Inc. 10.Bio Med Pvt. Ltd 11.Sinova 12.Grifols 13.AstraZeneca 14.Cadila Healthcare Ltd 15.CSL Limited. 16.Zydus Cadila 17.Panacea Biotech Frequently Asked Questions: 1. Which region has the largest share in Global Pediatric Vaccines Market? Ans: Asia Pacific region held the highest share in 2022. 2. What is the growth rate of Global Pediatric Vaccines Market? Ans: The Global Pediatric Vaccines Market is growing at a CAGR of 10.7% during forecasting period 2023-2029. 3. What is scope of the Global Pediatric Vaccines market report? Ans: Global Pediatric Vaccines Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Pediatric Vaccines market? Ans: The important key players in the Global Pediatric Vaccines Market are – Merck Sharp & Dohme Corp, SANOFI, Indian Immunologicals Limited, Mitsubishi Tanabe Pharma Corporation, Sinovac Biotech Ltd., GlaxoSmithKline plc., Serum Institute of India Pvt. Ltd., Eli Lilly Company, Pfizer, Inc., Bio Med Pvt. Ltd, Sinova, Grifols, AstraZeneca, Cadila Healthcare Ltd, CSL Limited., Zydus Cadila, and Panacea Biotech 5. What is the study period of this market? Ans: The Global Pediatric Vaccines Market is studied from 2022 to 2029.
pediatric vaccines market
1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Pediatric Vaccines Market Size, by Market Value (US$ Bn) and Market Volume (Units) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies in Pediatric Vaccines Market 5. Supply Side and Demand Side Indicators 6. Pediatric Vaccines Market Analysis and Forecast 6.1. Pediatric Vaccines Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Pediatric Vaccines Market Analysis and Forecast, by Vaccine Type 7.1. Introduction and Definition 7.2. Key Findings 7.3. Pediatric Vaccines Market Value Share Analysis, by Vaccine Type 7.4. Pediatric Vaccines Market Size (US$ Bn) Forecast, by Vaccine Type 7.5. Pediatric Vaccines Market Analysis, by Vaccine Type 7.6. Pediatric Vaccines Market Attractiveness Analysis, by Vaccine Type 8. Pediatric Vaccines Market Analysis and Forecast, by Technology 8.1. Introduction and Definition 8.2. Key Findings 8.3. Pediatric Vaccines Market Value Share Analysis, by Technology 8.4. Pediatric Vaccines Market Size (US$ Bn) Forecast, by Technology 8.5. Pediatric Vaccines Market Analysis, by Technology 8.6. Pediatric Vaccines Market Attractiveness Analysis, by Technology 9. Pediatric Vaccines Market Analysis and Forecast, by Application 9.1. Introduction and Definition 9.2. Key Findings 9.3. Pediatric Vaccines Market Value Share Analysis, by Application 9.4. Pediatric Vaccines Market Size (US$ Bn) Forecast, by Application 9.5. Pediatric Vaccines Market Analysis, by Application 9.6. Pediatric Vaccines Market Attractiveness Analysis, by Application 10. Pediatric Vaccines Market Analysis and Forecast, by End User 10.1. Introduction and Definition 10.2. Key Findings 10.3. Pediatric Vaccines Market Value Share Analysis, by End User 10.4. Pediatric Vaccines Market Size (US$ Bn) Forecast, by End User 10.5. Pediatric Vaccines Market Analysis, by End User 10.6. Pediatric Vaccines Market Attractiveness Analysis, by End User 11. Pediatric Vaccines Market Analysis, by Region 11.1. Pediatric Vaccines Market Value Share Analysis, by Region 11.2. Pediatric Vaccines Market Size (US$ Bn) Forecast, by Region 11.3. Pediatric Vaccines Market Attractiveness Analysis, by Region 12. North America Pediatric Vaccines Market Analysis 12.1. Key Findings 12.2. North America Pediatric Vaccines Market Overview 12.3. North America Pediatric Vaccines Market Value Share Analysis, by Vaccine Type 12.4. North America Pediatric Vaccines Market Forecast, by Vaccine Type 12.4.1. Monovalent 12.4.2. Multivalent 12.5. North America Pediatric Vaccines Market Value Share Analysis, by Technology 12.6. North America Pediatric Vaccines Market Forecast, by Technology 12.6.1. Attenuated Live Viruses 12.6.2. Inactivated Viruses 12.6.3. Recombinant 12.6.4. Subunits 12.6.5. Toxoids 12.6.6. Conjugates 12.6.7. Polysaccharides 12.7. North America Pediatric Vaccines Market Value Share Analysis, by Application 12.8. North America Pediatric Vaccines Market Forecast, by Application 12.8.1. Infectious Disease 12.8.2. Allergy 12.8.3. Cancer 12.8.4. Other 12.9. North America Pediatric Vaccines Market Value Share Analysis, by End User 12.10. North America Pediatric Vaccines Market Forecast, by End User 12.10.1. Hospitals 12.10.2. Pediatric Clinics 12.10.3. Others 12.11. North America Pediatric Vaccines Market Value Share Analysis, by Country 12.12. North America Pediatric Vaccines Market Forecast, by Country 12.12.1. U.S. 12.12.2. Canada 12.13. North America Pediatric Vaccines Market Analysis, by Country 12.14. U.S. Pediatric Vaccines Market Forecast, by Vaccine Type 12.14.1. Monovalent 12.14.2. Multivalent 12.15. U.S. Pediatric Vaccines Market Forecast, by Technology 12.15.1. Attenuated Live Viruses 12.15.2. Inactivated Viruses 12.15.3. Recombinant 12.15.4. Subunits 12.15.5. Toxoids 12.15.6. Conjugates 12.15.7. Polysaccharides 12.16. U.S. Pediatric Vaccines Market Forecast, by Application 12.16.1. Infectious Disease 12.16.2. Allergy 12.16.3. Cancer 12.16.4. Other 12.17. U.S. Pediatric Vaccines Market Forecast, by End User 12.17.1. Hospitals 12.17.2. Pediatric Clinics 12.17.3. Others 12.18. Canada Pediatric Vaccines Market Forecast, by Vaccine Type 12.18.1. Monovalent 12.18.2. Multivalent 12.19. Canada Pediatric Vaccines Market Forecast, by Technology 12.19.1. Attenuated Live Viruses 12.19.2. Inactivated Viruses 12.19.3. Recombinant 12.19.4. Subunits 12.19.5. Toxoids 12.19.6. Conjugates 12.19.7. Polysaccharides 12.20. Canada Pediatric Vaccines Market Forecast, by Application 12.20.1. Infectious Disease 12.20.2. Allergy 12.20.3. Cancer 12.20.4. Other 12.21. Canada Pediatric Vaccines Market Forecast, by End User 12.21.1. Hospitals 12.21.2. Pediatric Clinics 12.21.3. Others 12.22. North America Pediatric Vaccines Market Attractiveness Analysis 12.22.1. By Vaccine Type 12.22.2. By Technology 12.22.3. By Application 12.22.4. By End User 12.23. PEST Analysis 12.24. Key Trends 12.25. Key Developments 13. Europe Pediatric Vaccines Market Analysis 13.1. Key Findings 13.2. Europe Pediatric Vaccines Market Overview 13.3. Europe Pediatric Vaccines Market Value Share Analysis, by Vaccine Type 13.4. Europe Pediatric Vaccines Market Forecast, by Vaccine Type 13.4.1. Monovalent 13.4.2. Multivalent 13.5. Europe Pediatric Vaccines Market Value Share Analysis, by Technology 13.6. Europe Pediatric Vaccines Market Forecast, by Technology 13.6.1. Attenuated Live Viruses 13.6.2. Inactivated Viruses 13.6.3. Recombinant 13.6.4. Subunits 13.6.5. Toxoids 13.6.6. Conjugates 13.6.7. Polysaccharides 13.7. Europe Pediatric Vaccines Market Value Share Analysis, by Application 13.8. Europe Pediatric Vaccines Market Forecast, by Application 13.8.1. Infectious Disease 13.8.2. Allergy 13.8.3. Cancer 13.8.4. Other 13.9. Europe Pediatric Vaccines Market Value Share Analysis, by End User 13.10. Europe Pediatric Vaccines Market Forecast, by End User 13.10.1. Hospitals 13.10.2. Pediatric Clinics 13.10.3. Others 13.11. Europe Pediatric Vaccines Market Value Share Analysis, by Country 13.12. Europe Pediatric Vaccines Market Forecast, by Country 13.12.1. Germany 13.12.2. U.K. 13.12.3. France 13.12.4. Italy 13.12.5. Spain 13.12.6. Rest of Europe 13.13. Europe Pediatric Vaccines Market Analysis, by Country 13.14. Germany Pediatric Vaccines Market Forecast, by Vaccine Type 13.14.1. Monovalent 13.14.2. Multivalent 13.15. Germany Pediatric Vaccines Market Forecast, by Technology 13.15.1. Attenuated Live Viruses 13.15.2. Inactivated Viruses 13.15.3. Recombinant 13.15.4. Subunits 13.15.5. Toxoids 13.15.6. Conjugates 13.15.7. Polysaccharides 13.16. Germany Pediatric Vaccines Market Forecast, by Application 13.16.1. Infectious Disease 13.16.2. Allergy 13.16.3. Cancer 13.16.4. Other 13.17. Germany Pediatric Vaccines Market Forecast, by End User 13.17.1. Hospitals 13.17.2. Pediatric Clinics 13.17.3. Others 13.18. U.K. Pediatric Vaccines Market Forecast, by Vaccine Type 13.18.1. Monovalent 13.18.2. Multivalent 13.19. U.K. Pediatric Vaccines Market Forecast, by Technology 13.19.1. Attenuated Live Viruses 13.19.2. Inactivated Viruses 13.19.3. Recombinant 13.19.4. Subunits 13.19.5. Toxoids 13.19.6. Conjugates 13.19.7. Polysaccharides 13.20. U.K. Pediatric Vaccines Market Forecast, by Application 13.20.1. Infectious Disease 13.20.2. Allergy 13.20.3. Cancer 13.20.4. Other 13.21. U.K. Pediatric Vaccines Market Forecast, by End User 13.21.1. Hospitals 13.21.2. Pediatric Clinics 13.21.3. Others 13.22. France Pediatric Vaccines Market Forecast, by Vaccine Type 13.22.1. Monovalent 13.22.2. Multivalent 13.23. France Pediatric Vaccines Market Forecast, by Technology 13.23.1. Attenuated Live Viruses 13.23.2. Inactivated Viruses 13.23.3. Recombinant 13.23.4. Subunits 13.23.5. Toxoids 13.23.6. Conjugates 13.23.7. Polysaccharides 13.24. France Pediatric Vaccines Market Forecast, by Application 13.24.1. Infectious Disease 13.24.2. Allergy 13.24.3. Cancer 13.24.4. Other 13.25. France Pediatric Vaccines Market Forecast, by End User 13.25.1. Hospitals 13.25.2. Pediatric Clinics 13.25.3. Others 13.26. Italy Pediatric Vaccines Market Forecast, by Vaccine Type 13.26.1. Monovalent 13.26.2. Multivalent 13.27. Italy Pediatric Vaccines Market Forecast, by Technology 13.27.1. Attenuated Live Viruses 13.27.2. Inactivated Viruses 13.27.3. Recombinant 13.27.4. Subunits 13.27.5. Toxoids 13.27.6. Conjugates 13.27.7. Polysaccharides 13.28. Italy Pediatric Vaccines Market Forecast, by Application 13.28.1. Infectious Disease 13.28.2. Allergy 13.28.3. Cancer 13.28.4. Other 13.29. Italy Pediatric Vaccines Market Forecast, by End User 13.29.1. Hospitals 13.29.2. Pediatric Clinics 13.29.3. Others 13.30. Spain Pediatric Vaccines Market Forecast, by Vaccine Type 13.30.1. Monovalent 13.30.2. Multivalent 13.31. Spain Pediatric Vaccines Market Forecast, by Technology 13.31.1. Attenuated Live Viruses 13.31.2. Inactivated Viruses 13.31.3. Recombinant 13.31.4. Subunits 13.31.5. Toxoids 13.31.6. Conjugates 13.31.7. Polysaccharides 13.32. Spain Pediatric Vaccines Market Forecast, by Application 13.32.1. Infectious Disease 13.32.2. Allergy 13.32.3. Cancer 13.32.4. Other 13.33. Spain Pediatric Vaccines Market Forecast, by End User 13.33.1. Hospitals 13.33.2. Pediatric Clinics 13.33.3. Others 13.34. Rest of Europe Pediatric Vaccines Market Forecast, by Vaccine Type 13.34.1. Monovalent 13.34.2. Multivalent 13.35. Rest of Europe Pediatric Vaccines Market Forecast, by Technology 13.35.1. Attenuated Live Viruses 13.35.2. Inactivated Viruses 13.35.3. Recombinant 13.35.4. Subunits 13.35.5. Toxoids 13.35.6. Conjugates 13.35.7. Polysaccharides 13.36. Rest of Europe Pediatric Vaccines Market Forecast, by Application 13.36.1. Infectious Disease 13.36.2. Allergy 13.36.3. Cancer 13.36.4. Other 13.37. Rest Of Europe Pediatric Vaccines Market Forecast, by End User 13.37.1. Hospitals 13.37.2. Pediatric Clinics 13.37.3. Others 13.38. Europe Pediatric Vaccines Market Attractiveness Analysis 13.38.1. By Vaccine Type 13.38.2. By Technology 13.38.3. By Application 13.38.4. By End User 13.39. PEST Analysis 13.40. Key Trends 13.41. Key Developments 14. Asia Pacific Pediatric Vaccines Market Analysis 14.1. Key Findings 14.2. Asia Pacific Pediatric Vaccines Market Overview 14.3. Asia Pacific Pediatric Vaccines Market Value Share Analysis, by Vaccine Type 14.4. Asia Pacific Pediatric Vaccines Market Forecast, by Vaccine Type 14.4.1. Monovalent 14.4.2. Multivalent 14.5. Asia Pacific Pediatric Vaccines Market Value Share Analysis, by Technology 14.6. Asia Pacific Pediatric Vaccines Market Forecast, by Technology 14.6.1. Attenuated Live Viruses 14.6.2. Inactivated Viruses 14.6.3. Recombinant 14.6.4. Subunits 14.6.5. Toxoids 14.6.6. Conjugates 14.6.7. Polysaccharides 14.7. Asia Pacific Pediatric Vaccines Market Value Share Analysis, by Application 14.8. Asia Pacific Pediatric Vaccines Market Forecast, by Application 14.8.1. Infectious Disease 14.8.2. Allergy 14.8.3. Cancer 14.8.4. Other 14.9. Asia Pacific Pediatric Vaccines Market Value Share Analysis, by End User 14.10. Asia Pacific Pediatric Vaccines Market Forecast, by End User 14.10.1. Hospitals 14.10.2. Pediatric Clinics 14.10.3. Others 14.11. Asia Pacific Pediatric Vaccines Market Value Share Analysis, by Country 14.12. Asia Pacific Pediatric Vaccines Market Forecast, by Country 14.12.1. China 14.12.2. India 14.12.3. Japan 14.12.4. ASEAN 14.12.5. Rest of Asia Pacific 14.13. Asia Pacific Pediatric Vaccines Market Analysis, by Country 14.14. China Pediatric Vaccines Market Forecast, by Vaccine Type 14.14.1. Monovalent 14.14.2. Multivalent 14.15. China Pediatric Vaccines Market Forecast, by Technology 14.15.1. Attenuated Live Viruses 14.15.2. Inactivated Viruses 14.15.3. Recombinant 14.15.4. Subunits 14.15.5. Toxoids 14.15.6. Conjugates 14.15.7. Polysaccharides 14.16. China Pediatric Vaccines Market Forecast, by Application 14.16.1. Infectious Disease 14.16.2. Allergy 14.16.3. Cancer 14.16.4. Other 14.17. China Pediatric Vaccines Market Forecast, by End User 14.17.1. Hospitals 14.17.2. Pediatric Clinics 14.17.3. Others 14.18. India Pediatric Vaccines Market Forecast, by Vaccine Type 14.18.1. Monovalent 14.18.2. Multivalent 14.19. India Pediatric Vaccines Market Forecast, by Technology 14.19.1. Attenuated Live Viruses 14.19.2. Inactivated Viruses 14.19.3. Recombinant 14.19.4. Subunits 14.19.5. Toxoids 14.19.6. Conjugates 14.19.7. Polysaccharides 14.20. India Pediatric Vaccines Market Forecast, by Application 14.20.1. Infectious Disease 14.20.2. Allergy 14.20.3. Cancer 14.20.4. Other 14.21. India Pediatric Vaccines Market Forecast, by End User 14.21.1. Hospitals 14.21.2. Pediatric Clinics 14.21.3. Others 14.22. Japan Pediatric Vaccines Market Forecast, by Vaccine Type 14.22.1. Monovalent 14.22.2. Multivalent 14.23. Japan Pediatric Vaccines Market Forecast, by Technology 14.23.1. Attenuated Live Viruses 14.23.2. Inactivated Viruses 14.23.3. Recombinant 14.23.4. Subunits 14.23.5. Toxoids 14.23.6. Conjugates 14.23.7. Polysaccharides 14.24. Japan Pediatric Vaccines Market Forecast, by Application 14.24.1. Infectious Disease 14.24.2. Allergy 14.24.3. Cancer 14.24.4. Other 14.25. Japan Pediatric Vaccines Market Forecast, by End User 14.25.1. Hospitals 14.25.2. Pediatric Clinics 14.25.3. Others 14.26. ASEAN Pediatric Vaccines Market Forecast, by Vaccine Type 14.26.1. Monovalent 14.26.2. Multivalent 14.27. ASEAN Pediatric Vaccines Market Forecast, by Technology 14.27.1. Attenuated Live Viruses 14.27.2. Inactivated Viruses 14.27.3. Recombinant 14.27.4. Subunits 14.27.5. Toxoids 14.27.6. Conjugates 14.27.7. Polysaccharides 14.28. ASEAN Pediatric Vaccines Market Forecast, by Application 14.28.1. Infectious Disease 14.28.2. Allergy 14.28.3. Cancer 14.28.4. Other 14.29. ASEAN Pediatric Vaccines Market Forecast, by End User 14.29.1. Hospitals 14.29.2. Pediatric Clinics 14.29.3. Others 14.30. Rest of Asia Pacific Pediatric Vaccines Market Forecast, by Vaccine Type 14.30.1. Monovalent 14.30.2. Multivalent 14.31. Rest of Asia Pacific Pediatric Vaccines Market Forecast, by Technology 14.31.1. Attenuated Live Viruses 14.31.2. Inactivated Viruses 14.31.3. Recombinant 14.31.4. Subunits 14.31.5. Toxoids 14.31.6. Conjugates 14.31.7. Polysaccharides 14.32. Rest of Asia Pacific Pediatric Vaccines Market Forecast, by Application 14.32.1. Infectious Disease 14.32.2. Allergy 14.32.3. Cancer 14.32.4. Other 14.33. Rest of Asia Pacific Pediatric Vaccines Market Forecast, by End User 14.33.1. Hospitals 14.33.2. Pediatric Clinics 14.33.3. Others 14.34. Asia Pacific Pediatric Vaccines Market Attractiveness Analysis 14.34.1. By Vaccine Type 14.34.2. By Technology 14.34.3. By Application 14.34.4. By End User 14.35. PEST Analysis 14.36. Key Trends 14.37. Key Developments 15. Middle East & Africa Pediatric Vaccines Market Analysis 15.1. Key Findings 15.2. Middle East & Africa Pediatric Vaccines Market Overview 15.3. Middle East & Africa Pediatric Vaccines Market Value Share Analysis, by Vaccine Type 15.4. Middle East & Africa Pediatric Vaccines Market Forecast, by Vaccine Type 15.4.1. Monovalent 15.4.2. Multivalent 15.5. Middle East & Africa Pediatric Vaccines Market Value Share Analysis, by Technology 15.6. Middle East & Africa Pediatric Vaccines Market Forecast, by Technology 15.6.1. Attenuated Live Viruses 15.6.2. Inactivated Viruses 15.6.3. Recombinant 15.6.4. Subunits 15.6.5. Toxoids 15.6.6. Conjugates 15.6.7. Polysaccharides 15.7. Middle East & Africa Pediatric Vaccines Market Value Share Analysis, by Application 15.8. Middle East & Africa Pediatric Vaccines Market Forecast, by Application 15.8.1. Infectious Disease 15.8.2. Allergy 15.8.3. Cancer 15.8.4. Other 15.9. Middle East & Africa Pediatric Vaccines Market Value Share Analysis, by End User 15.10. Middle East & Africa Pediatric Vaccines Market Forecast, by End User 15.10.1. Hospitals 15.10.2. Pediatric Clinics 15.10.3. Others 15.11. Middle East & Africa Pediatric Vaccines Market Value Share Analysis, by Country 15.12. Middle East & Africa Pediatric Vaccines Market Forecast, by Country 15.12.1. GCC 15.12.2. South Africa 15.12.3. Rest of Middle East & Africa 15.13. Middle East & Africa Pediatric Vaccines Market Analysis, by Country 15.14. GCC Pediatric Vaccines Market Forecast, by Vaccine Type 15.14.1. Monovalent 15.14.2. Multivalent 15.15. GCC Pediatric Vaccines Market Forecast, by Technology 15.15.1. Attenuated Live Viruses 15.15.2. Inactivated Viruses 15.15.3. Recombinant 15.15.4. Subunits 15.15.5. Toxoids 15.15.6. Conjugates 15.15.7. Polysaccharides 15.16. GCC Pediatric Vaccines Market Forecast, by Application 15.16.1. Infectious Disease 15.16.2. Allergy 15.16.3. Cancer 15.16.4. Other 15.17. GCC Pediatric Vaccines Market Forecast, by End User 15.17.1. Hospitals 15.17.2. Pediatric Clinics 15.17.3. Others 15.18. South Africa Pediatric Vaccines Market Forecast, by Vaccine Type 15.18.1. Monovalent 15.18.2. Multivalent 15.19. South Africa Pediatric Vaccines Market Forecast, by Technology 15.19.1. Attenuated Live Viruses 15.19.2. Inactivated Viruses 15.19.3. Recombinant 15.19.4. Subunits 15.19.5. Toxoids 15.19.6. Conjugates 15.19.7. Polysaccharides 15.20. South Africa Pediatric Vaccines Market Forecast, by Application 15.20.1. Infectious Disease 15.20.2. Allergy 15.20.3. Cancer 15.20.4. Other 15.21. South Africa Pediatric Vaccines Market Forecast, by End User 15.21.1. Hospitals 15.21.2. Pediatric Clinics 15.21.3. Others 15.22. Rest of Middle East & Africa Pediatric Vaccines Market Forecast, by Vaccine Type 15.22.1. Monovalent 15.22.2. Multivalent 15.23. Rest of Middle East & Africa Pediatric Vaccines Market Forecast, by Technology 15.23.1. Attenuated Live Viruses 15.23.2. Inactivated Viruses 15.23.3. Recombinant 15.23.4. Subunits 15.23.5. Toxoids 15.23.6. Conjugates 15.23.7. Polysaccharides 15.24. Rest of Middle East & Africa Pediatric Vaccines Market Forecast, by Application 15.24.1. Infectious Disease 15.24.2. Allergy 15.24.3. Cancer 15.24.4. Other 15.25. Rest of Middle East & Africa Pediatric Vaccines Market Forecast, by End User 15.25.1. Hospitals 15.25.2. Pediatric Clinics 15.25.3. Others 15.26. Middle East & Africa Pediatric Vaccines Market Attractiveness Analysis 15.26.1. By Vaccine Type 15.26.2. By Technology 15.26.3. By Application 15.26.4. By End User 15.27. PEST Analysis 15.28. Key Trends 15.29. Key Developments 16. South America Pediatric Vaccines Market Analysis 16.1. Key Findings 16.2. South America Pediatric Vaccines Market Overview 16.3. South America Pediatric Vaccines Market Value Share Analysis, by Vaccine Type 16.4. South America Pediatric Vaccines Market Forecast, by Vaccine Type 16.4.1. Monovalent 16.4.2. Multivalent 16.5. South America Pediatric Vaccines Market Value Share Analysis, by Technology 16.6. South America Pediatric Vaccines Market Forecast, by Technology 16.6.1. Attenuated Live Viruses 16.6.2. Inactivated Viruses 16.6.3. Recombinant 16.6.4. Subunits 16.6.5. Toxoids 16.6.6. Conjugates 16.6.7. Polysaccharides 16.7. South America Pediatric Vaccines Market Value Share Analysis, by Application 16.8. South America Pediatric Vaccines Market Forecast, by Application 16.8.1. Infectious Disease 16.8.2. Allergy 16.8.3. Cancer 16.8.4. Other 16.9. South America Pediatric Vaccines Market Value Share Analysis, by End User 16.10. South America Pediatric Vaccines Market Forecast, by End User 16.10.1. Hospitals 16.10.2. Pediatric Clinics 16.10.3. Others 16.11. South America Pediatric Vaccines Market Value Share Analysis, by Country 16.12. South America Pediatric Vaccines Market Forecast, by Country 16.12.1. Brazil 16.12.2. Mexico 16.12.3. Rest of South America 16.13. South America Pediatric Vaccines Market Analysis, by Country 16.14. Brazil Pediatric Vaccines Market Forecast, by Vaccine Type 16.14.1. Monovalent 16.14.2. Multivalent 16.15. Brazil Pediatric Vaccines Market Forecast, by Technology 16.15.1. Attenuated Live Viruses 16.15.2. Inactivated Viruses 16.15.3. Recombinant 16.15.4. Subunits 16.15.5. Toxoids 16.15.6. Conjugates 16.15.7. Polysaccharides 16.16. Brazil Pediatric Vaccines Market Forecast, by Application 16.16.1. Infectious Disease 16.16.2. Allergy 16.16.3. Cancer 16.16.4. Other 16.17. Brazil Pediatric Vaccines Market Forecast, by End User 16.17.1. Hospitals 16.17.2. Pediatric Clinics 16.17.3. Others 16.18. Mexico Pediatric Vaccines Market Forecast, by Vaccine Type 16.18.1. Monovalent 16.18.2. Multivalent 16.19. Mexico Pediatric Vaccines Market Forecast, by Technology 16.19.1. Attenuated Live Viruses 16.19.2. Inactivated Viruses 16.19.3. Recombinant 16.19.4. Subunits 16.19.5. Toxoids 16.19.6. Conjugates 16.19.7. Polysaccharides 16.20. Mexico Pediatric Vaccines Market Forecast, by Application 16.20.1. Infectious Disease 16.20.2. Allergy 16.20.3. Cancer 16.20.4. Other 16.21. Mexico Pediatric Vaccines Market Forecast, by End User 16.21.1. Hospitals 16.21.2. Pediatric Clinics 16.21.3. Others 16.22. Rest of South America Pediatric Vaccines Market Forecast, by Vaccine Type 16.22.1. Monovalent 16.22.2. Multivalent 16.23. Rest of South America Pediatric Vaccines Market Forecast, by Technology 16.23.1. Attenuated Live Viruses 16.23.2. Inactivated Viruses 16.23.3. Recombinant 16.23.4. Subunits 16.23.5. Toxoids 16.23.6. Conjugates 16.23.7. Polysaccharides 16.24. Rest of South America Pediatric Vaccines Market Forecast, by Application 16.24.1. Infectious Disease 16.24.2. Allergy 16.24.3. Cancer 16.24.4. Other 16.25. Rest of South America Pediatric Vaccines Market Forecast, by End User 16.25.1. Hospitals 16.25.2. Pediatric Clinics 16.25.3. Others 16.26. South America Pediatric Vaccines Market Attractiveness Analysis 16.26.1. By Vaccine Type 16.26.2. By Technology 16.26.3. By Application 16.26.4. By End User 16.27. PEST Analysis 16.28. Key Trends 16.29. Key Developments 17. Company Profiles 17.1. Market Share Analysis, by Company 17.2. Competition Matrix 17.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 17.2.2. New Product Launches and Product Enhancements 17.2.3. Market Consolidation 17.2.3.1. M&A by Regions, Investment and Applications M&A Key Players, Forward Integration and Backward Integration 17.3. Company Profiles: Key Players 17.3.1. Merck Sharp & Dohme Corp 17.3.1.1. Company Overview 17.3.1.2. Financial Overview 17.3.1.3. Product Portfolio 17.3.1.4. Business Strategy 17.3.1.5. Recent Developments 17.3.1.6. Manufacturing Footprint 17.3.2. SANOFI 17.3.3. Indian Immunologicals Limited 17.3.4. Mitsubishi Tanabe Pharma Corporation 17.3.5. Sinovac Biotech Ltd. 17.3.6. GlaxoSmithKline plc. 17.3.7. Serum Institute of India Pvt. Ltd. 17.3.8. Eli Lilly Company 17.3.9. Pfizer, Inc. 17.3.10. Bio Med Pvt. Ltd 17.3.11. Sinova 17.3.12. Grifols 17.3.13. AstraZeneca 17.3.14. Cadila Healthcare Ltd 17.3.15. CSL Limited. 17.3.16. Zydus Cadila 17.3.17. Panacea Biotech 18. Primary Key Insights